An mRNA Cancer Vaccine Gave One Melanoma Patient a Path Forward
A melanoma diagnosis led one patient to an investigational mRNA cancer vaccine, STAT reports — a story that signals where skin-cancer immunotherapy is heading next.
Topic
Checkpoint Inhibitor
Topic
Checkpoint Inhibitor
Moderna, Merck Say mRNA Melanoma Vaccine Succeeded in Phase 3
Moderna and Merck say their personalized mRNA cancer vaccine succeeded in a Phase 3 melanoma trial — a first for the mRNA platfor…